Optimizing Informed Consent—A Call to Action

This Viewpoint discusses the US Food and Drug Administration’s proposal for a collaborative approach toward clarifying the informed consent process for potential clinical trial participants.

from JAMA Health Forum New Online https://ift.tt/kceYmlK